SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.660-2.4%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: donpat12/9/2014 8:38:43 PM
  Read Replies (2) of 12871
 
Progress...ok to post if either of you [FN or Me] wish to do so

EUGENE SEYMOUR
8:13 PM (21 minutes ago)

I'm not bothered by any posters even those who post untruths and neither should you be

They serve a very important purpose

Whenever any person makes inaccurate statements, others jump in to correct them so there's a constant dialogue and the truth gets repeated over and over again.

When I said it has been a "helluva year", I meant it!

Uplisting to a national exchange, raising of $27M for a total of $42M, a very desirable contract with USAMRIID for EbolaCide testing, creation of multiple candidates of a drug for Ebola, an innovation award for FluCide, as well as construction of a state of the art manufacturing facility. Also, initiation of toxicology studies on FluCide, progressive scale-up of FluCide samples and further demonstration of the safety of the drug candidate in animals!

Remember, we're creating new science here that can't be done overnight. Once the scale-up to 100 liter batches per bioreactor is completed, it's done! This then allows for production of much larger amounts in a much shorter time frame. The Shelton facility can handle multiple 100 liter capacity bioreactors.

You have no idea how laborious a task it is to do the scale-up. Fortunately, we've been able to hire qualified people who will help speed up the process

Also, there are all these complaints about the 200 grams we sent BASI for the start of the tox studies. That's all they needed. They will ask for more for large animals once the small animal studies are completed. We will then make it.

Also, the dates listed for human trials in the US don't mean that those will be the first FluCide trials. We've said many times that the FluCide trials will start much earlier in Australia because the bureaucratic restrictions are much less. We've stated that US trials will commence after successful sale of FluCide in jurisdictions outside of the U.S.

We simply use the U.S. as a reference point that everyone understands.

In addition, I've said many times that the availability of sale of FluCide in the EU and UK if it successfully completes initial Phase I/IIa trials is a tremendous boon to the company and may well result in a significant income stream.

So now you should understand why I feel it's been "a helluva year"

Sincerely,

Eugene Seymour, MD MPH
Chief Executive Officer
NanoViricides, Inc
310-486-5677
A New York Stock Exchange Company

Sent from my iPad

On Dec 9, 2014, at 10:47 AM, FN wrote:

I hope you do not take my last email in a wrong way
I know there is a lot at stake.
I understand the importance of NNVC with Ebola and Flucide.
I defends you on iHub with all those attasks.
I created a NANOCLUB which is expanding with NNVC shareholders.
But it is certain that I have a reaction when I saw the stock so low this morning.
And I think something has to be done with the man who constantly attack you, and which I think is at the origin of the fall of nnvc this morning.

Sincerly
FN
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext